143 related articles for article (PubMed ID: 7437528)
1. The role of alloimmunization in platelet survival studies.
Mueller-Eckhardt G; Breidenbach M; Mahn I; Mueller-Eckhardt C
Blut; 1980 Aug; 41(2):93-9. PubMed ID: 7437528
[TBL] [Abstract][Full Text] [Related]
2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
3. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
4. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
Godeau B; Fromont P; Seror T; Duedari N; Bierling P
Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
[TBL] [Abstract][Full Text] [Related]
5. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
6. A specific assay for anti-HLA antibodies: application to platelet donor selection.
Millard FE; Tani P; McMillan R
Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
[TBL] [Abstract][Full Text] [Related]
7. The problem of platelet autoantibodies. I. Evaluation of the platelet factor 3 availability test for their detection.
Mueller-Eckhardt C; Mersch-Baumert K
Vox Sang; 1977 Oct; 33(4):221-33. PubMed ID: 331683
[TBL] [Abstract][Full Text] [Related]
8. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
9. Detection of platelet alloimmunity with a platelet-associated IgG assay.
Myers TJ; Kim BK; Steiner M; Bishop J; Baldini MG
J Lab Clin Med; 1981 Jun; 97(6):854-63. PubMed ID: 7014743
[TBL] [Abstract][Full Text] [Related]
10. Platelet alloantibodies in transfused patients.
Kiefel V; König C; Kroll H; Santoso S
Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization.
Mandelbaum M; Koren D; Eichelberger B; Auerbach L; Panzer S
Vox Sang; 2005 Jul; 89(1):39-43. PubMed ID: 15938738
[TBL] [Abstract][Full Text] [Related]
12. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
Basire A; Picard C
Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
[TBL] [Abstract][Full Text] [Related]
13. Use of HLA- and HPA--matched platelets in alloimmunized patients.
Kekomäki R
Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
[TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
Freedman J; Gafni A; Garvey MB; Blanchette V
Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
[TBL] [Abstract][Full Text] [Related]
15. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
Brubaker DB; Romine M
Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
[TBL] [Abstract][Full Text] [Related]
16. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of platelet alloantibodies detected in immunofluorescence test (neonatal alloimmune thrombocytopenia and post-transfusion purpura).
Maślanka K; Zupańska B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):760-8. PubMed ID: 2416653
[TBL] [Abstract][Full Text] [Related]
18. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
Májský A; Fortýnová J; Vopatová M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
[TBL] [Abstract][Full Text] [Related]
19. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
Yam P; Petz LD; Scott EP; Santos S
Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
[TBL] [Abstract][Full Text] [Related]
20. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
